Well, I don’t think so, but I want to hear what you think! Can you spare 10 minutes today to give ASA a glimpse into your medical cannabis experiences ..read more

Yesterday, the South Carolina Senate voted in favor of a “call for a special order,” allowing the Compassionate Care Act to move forward in the Senate! Floor debates on the bill start today!   ..read more

For over 2 decades Americans for Safe Access (ASA) has been advocating for a change in the scheduling of cannabis to recognize its medical use. We are excited to see that the Food & Drug Administration (FDA) incorporated many of our suggestions into their approach to the scheduling process and were able to utilize ASA’s data in reaching their conclusion that cannabis does in fact have accepted medical use ..read more

on January 8, 2024, Indiana Representative Lucas (R-69) introduced House Bill 1146 simply titled “Medical Marijuana” The bill summary describes HB 1146’s function as follows ..read more

As we step into a new year, it's time to reflect on the headlines we hope to see in the world of medical cannabis in 2024 and make a commitment to turn these hopes into reality. Picture this: "Congress Makes Medical Cannabis Legal Nationwide, Creates New Office in HHS to Improve Access" and "New Federal Law Opens Door for Insurers to Cover Medical Cannabis" gracing the front pages of every newspaper ..read more

For over 20 years, we have had the honor to work alongside our incredible members and supporters. It hasn’t been an easy road and there is still so much to do. In the spirit of the holidays we wanted to take a minute to say thank you to all of you and to share some of the things we are thankful for this year ..read more

Navigating Medical Cannabis in the Federal Arena The news of Health and Human Services’ (HHS) recommendation to move Cannabis to a Schedule III status created a flurry of media coverage and press statements from various cannabis stakeholders and elected officials about the impact of such an action. Much of the focus was on the impact this would have on the current state-level cannabis businesses and often confused what would be possible under Schedule III with what will actually happen when the scheduling process at the Department of Justice (DOJ) is complete ..read more

What just Happened On Wednesday, Bloomberg news reported that Health and Human Services (HHS) is recommending that cannabis be rescheduled to Schedule III following the Food and Drug Administration’s (FDA) scientific review of cannabis under the direction of President Biden. Their findings were sent to the Drug Enforcement Administration (DEA) who will be performing the final review for the Department of Justice (DOJ) in response to President Biden’s request in October 2022 for HHS and DOJ to look into the scheduling of cannabis.  As someone who has spent the last twenty plus years of my ..read more

Last week, Americans for Safe Access responded to a bicameral Congressional Request for Information on cannabinoid hemp regulation from the U.S. House Committee on Energy & Commerce and the U.S. Senate Committee on Health, Education, Labor, and Pensions ..read more

Let’s be honest, medical cannabis is not the most pressing issue in Washington these days. I have experienced firsthand from walking the halls of Congress, that while a majority of members are sympathetic to the needs of patients, most do not understand the issue of medical cannabis much less that there is a way forward ..read more